Latest Pluripotency Stories
MADISON, Wis., March 22, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCellÂ® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of developing drug candidates was completed early and is now transitioning into a standard supply agreement.
PARIS, March 8, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the genome engineering specialist, and Etablissement Francais du Sang (EFS), the only civilian blood transfusion service in France, announce that StemRed, an ambitious collaborative program to produce red blood cells from induced pluripotent stem cells (iPS cells) has started on March 1.
In the past few months, a slew of papers have indicated that the therapeutic potential of a promising type of stem cell, called induced pluripotent stem (iPS) cells, might be limited by reprogramming errors and genomic instability.
"Pluripotent" stem cellsâ€”which have the potential to mature into almost any cell in the bodyâ€”are being widely studied for their role in treating a vast array of human diseases and for generating cells and tissues for transplantation.
MADISON, Wis., March 4, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI), the world's largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells (iPSCs) under a feeder-free condition using chemically defined media.
Discovery opens avenue for research into new veterinary and human treatments for a range of degenerative conditions.
Ever since researchers devised a recipe for turning adult cells into cells that look and act like embryonic stem cells, there has been lingering doubt in the field about just how close to embryonic stem cells each of those cell lines really is at a molecular and functional level.
A new study to generate replacement tissue in the lab faced questions on Thursday over mature cells whose DNA is "reprogrammed" so that they grow with youthful vigor into new cells.
Reprogramming adult cells to recapture their youthful "can-do-it-all" attitude appears to leave an indelible mark, found researchers at the Salk Institute for Biological Studies.
Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells.